GlassScriptPhysician profile
James J Tayoun
NPI 1811908924
$6,821.47
in general payments reported to CMS, 2019-2025
11 companies · $324 in 2025
The $324 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $961 · 2020: $36.82 · 2022: $205 · 2023: $4,925 · 2024: $370 · 2025: $324.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $2,500 · Travel and Lodging: $2,277 · Food and Beverage: $842.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $2,500.00 |
| Travel and Lodging | $2,276.67 |
| Food and Beverage | $841.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $5,033.83 | 2023-2025 | Davinci Xi, Da Vinci Surgical System |
| Boston Scientific Corporation | $997.48 | 2019-2025 | Enroute Transcarotid Neuroprotection System |
| Endologix LLC | $349.33 | 2022-2024 | Torus Stent Graft System, Endocross Device |
| Abbvie INC. | $205.10 | 2023-2025 | Dalvance |
| Ethicon US, LLC | $109.39 | 2025 | Echelon Flex |
| Misonix INC | $36.82 | 2020 | |
| Lifenet Health | $25.15 | 2023 | |
| Integra Lifesciences Corporation | $18.98 | 2023 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Davol INC. | $16.51 | 2022 | |
| Avanos Medical | $14.71 | 2022 | |
| Pacira Pharmaceuticals Incorporated | $14.17 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Tayoun listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.